Yahoo
Shanghai - Delayed Quote CNY

Micro-Tech (Nanjing) Co.,Ltd (688029.SS)

84.08 +3.48 (+4.32%)
At close: 3:00:00 PM GMT+8
Chart Range Bar
Loading chart for 688029.SS
  • Previous Close 80.60
  • Open 80.61
  • Bid 84.08 x --
  • Ask 84.10 x --
  • Day's Range 80.21 - 85.00
  • 52 Week Range 65.70 - 89.93
  • Volume 3,443,798
  • Avg. Volume 2,574,164
  • Market Cap (intraday) 15.794B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 30.69
  • EPS (TTM) 2.74
  • Earnings Date --
  • Forward Dividend & Yield 1.50 (1.86%)
  • Ex-Dividend Date Oct 23, 2026
  • 1y Target Est 97.51

Micro-Tech (Nanjing) Co.,Ltd, together with its subsidiaries, engages in the research, development, manufacturing, and sale of minimally invasive medical devices in China and internationally. The company offers digestive endoscopy products, including ESD, such as electric flushing device, harmony/GT gold clip, gold/titanium knife, pull clamp, three-arm clap, hemostatic titanium forceps, injection needle, vascular clamp, spray pipe, electric oil, and indigo carmine muscosal staining agent; and ERCP comprising biliary duct drainage tube, nasobiliary drainage catheter, stone removal balloon, stone retrieval basket, level 3 balloon dilation catheter, guide wire, ruyi knife, and eyemax insights. It also provides hemostasis, which includes bandage and star king clip; dilation and biopsy, such as covered biliary stent, biliary stent, intestinal stent kit with biopsy access, intestinal stent, covered intestinal stent, segmented esophageal stent system, and covered esophageal stent kit; EUS comprising ultrasonic water bag and ultrasonic needle; cell brush; and net ring toss, cleaning brush, mouth pad, and foreign body forceps. In addition, the company offers interventional radiology and surgical devices. The company was founded in 2000 and is headquartered in Nanjing, China.

www.micro-tech.com.cn

2,433

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/2/2026, which may include dividends or other distributions. Benchmark is SSE Composite Index (000001.SS) .

YTD Return

688029.SS
5.19%
SSE Composite Index (000001.SS)
8.34%

1-Year Return

688029.SS
3.52%
SSE Composite Index (000001.SS)
8.01%

3-Year Return

688029.SS
2.33%
SSE Composite Index (000001.SS)
20.89%

5-Year Return

688029.SS
48.81%
SSE Composite Index (000001.SS)
3.78%

Analyst Insights

View More

Analyst Price Targets

90.60
97.51 Average
84.08 Current
102.00 High

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    14.37%

  • Return on Assets (ttm)

    7.50%

  • Return on Equity (ttm)

    11.04%

  • Revenue (ttm)

    3.32B

  • Net Income Avi to Common (ttm)

    477.13M

  • Diluted EPS (ttm)

    2.74

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    1.77B

  • Total Debt/Equity (mrq)

    7.01%

  • Levered Free Cash Flow (ttm)

    169.67M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: